Jean Bennett's Insider Trades & SAST Disclosures
Jean Bennett's most recent trade in Opus Genetics Inc. was a trade of 79,592 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 30, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jean Bennett.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Opus Genetics Inc. | Jean Bennett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2025 | 79,592 | 79,592 | - | - | Stock Option (Right to Buy) | |
| Opus Genetics Inc. | Jean Bennett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2025 | 79,504 | 213,525 | - | 0 | Common Stock | |
| Opus Genetics Inc. | Jean Bennett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 34,021 | 134,021 | - | - | Common Stock | |
| Opus Genetics Inc. | Jean Bennett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Oct 2024 | 172,874 | 172,874 | - | - | Stock Option (right to buy) | |
| Opus Genetics Inc. | Jean Bennett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Oct 2024 | 100,000 | 100,000 | - | 0 | Common Stock | |
| Regenxbio Inc | Jean Bennett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 24,454 | 24,454 | - | - | Stock Options (Right to Buy) | |
| Regenxbio Inc | Jean Bennett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 4,790 | 11,286 (0%) | 0% | 0 | Common Stock | |
| Regenxbio Inc | Jean Bennett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2023 | 17,892 | 17,892 | - | - | Stock Options (Right to Buy) | |
| Regenxbio Inc | Jean Bennett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2023 | 3,486 | 6,496 (0%) | 0% | 0 | Common Stock | |
| Regenxbio Inc | Jean Bennett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2022 | 15,324 | 15,324 | - | - | Stock Option (Right to Buy) | |
| Regenxbio Inc | Jean Bennett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2022 | 3,010 | 3,010 (0%) | 0% | 0 | Common Stock | |
| Regenxbio Inc | Jean Bennett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Sep 2021 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges